DAVID E. I. PYOTT - 23 Feb 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Andrew Mayer, Attorney-in-Fact For: David E.I. Pyott
Issuer symbol
ALNY
Transactions as of
23 Feb 2023
Net transactions value
$0
Form type
4
Filing time
27 Feb 2023, 15:13:02 UTC
Previous filing
21 Jun 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $0 +136 $0.000000 136 23 Feb 2023 Direct
holding ALNY Common Stock 27,900 23 Feb 2023 by Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Restricted Stock Units Options Exercise $0 -136 -100% $0.000000* 0 23 Feb 2023 Common Stock 136 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
F2 Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F3 This award vested on February 23, 2023, the first anniversary of the grant date.